Ginsenoside F2

SKU: orb1303570

Description

Ginsenoside F2 is a research compound that selectively targets breast cancer stem cells (CSCs), inhibiting their proliferation. It promotes apoptosis in these cells through intrinsic pathway activation and mitochondrial disruption, as demonstrated in in vitro studies. This activity makes it a valuable tool for investigating CSC biology and potential therapeutic strategies.

Research Area

Cell Biology, Metabolism Research

Key Properties

• CAS Number: 62025-49-4
• MW: 785.01
• Purity: 99.30% (May vary between batches)
• Formula: C₄₂H₇₂O₁₃
• SMILES: [H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@]3([H])CC[C@@]21C)[C@](C)(CCC=C(C)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
• Target: Autophagy|||Endogenous Metabolite|||Apoptosis
• Solubility: H2O:2.08 mg/mL (2.65 mM);DMSO:120 mg/mL (152.86 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (2.55 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

inhibit, Inhibitor, EndogenousMetabolite, Endogenous Metabolite, Ginsenoside F 2, Ginsenoside F2, Ginsenoside F-2, Apoptosis, Apoptosis inducer, Autophagy

Compound Identifiers

PubChem CID

9918692